TY - JOUR AU - Govind Shukla, AU - Nagalakshmi Yaparthy, AU - D.Sruthi Rao, AU - C.J. Sampath Kumar , PY - 2021/05/28 Y2 - 2024/03/28 TI - FLORALITE Capsules: cancer supportive therapy for chemotherapy-induced diarrhea (CID) JF - International Journal of Research in Pharmacology & Pharmacotherapeutics JA - Int. J. of Res. in Pharmacology &Pharmacotherapeutics VL - 5 IS - 4 SE - Articles DO - 10.61096/ijrpp.v5.iss4.2016.306-310 UR - https://ijrpp.com/ijrpp/article/view/367 SP - 306-310 AB - Diarrhea is a common side effect of chemotherapy regimens. Diarrhea can cause depletion of fluids and electrolytes, malnutrition, and dehydration. Chemotherapy-induced diarrhea (CID) can occur in as many as 50-80 percent of patients receiving chemotherapy. Probiotics have been shown effective at preventing diarrhea in inflammatory bowel disease and may prove useful in the oncology setting, Clinical research indicates that probiotics promote a healthy balance of intestinal flora and has immunomodulatory effects in cancer patients and may help minimize some of the negative gastrointestinal side effects associated with treatment. This article reviews the current available scientific literature regarding the effect of Floralite capsules in promoting immune function & As supportive therapy for chemotherapy induced diarrhea. ER -